Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.21%, near the low end of its 5-year range (0.00%–0.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 0.00%.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.01%
DEBT TO ASSETS RATIO AVG 5Y
0.21%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 730 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Immunovant, Inc.
Market Cap
$6.65B
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.01%
5Y Avg
0.21%
Market Cap
$6.58B
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.54B
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.51B
Debt to Assets Ratio
0.26%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.44B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.98B
Debt to Assets Ratio
0.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.65B | 0.00% | 0.00% | 0.01% | 0.21% |
| Chemed Corporation (CHE)vs › | $6.68B | 0.21% | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.58B | 0.43% | N/A | N/A | N/A |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.54B | 0.74% | N/A | N/A | N/A |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 0.26% | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.44B | 0.01% | N/A | N/A | N/A |
| Alkermes plc (ALKS)vs › | $7.08B | 0.36% | N/A | N/A | N/A |
| GRAIL Inc. (GRAL)vs › | $5.98B | 0.03% | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.98B | 0.52% | N/A | N/A | N/A |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.39B | 0.81% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
7.27
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.01% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.01% |
| 2024-12-31 | 0.01% |
| 2024-09-30 | 0.01% |
| 2024-06-30 | 0.01% |
| 2024-03-31 | 0.02% |
| 2023-12-31 | 0.04% |
| 2023-09-30 | 0.21% |
| 2023-06-30 | 0.26% |
| 2023-03-31 | 0.30% |
| 2022-12-31 | 0.33% |
| 2022-09-30 | 0.42% |
| 2022-06-30 | 0.45% |
| 2022-03-31 | 0.46% |
| 2021-12-31 | 0.51% |
| 2021-09-30 | 0.54% |
| 2021-06-30 | 0.79% |
| 2021-03-31 | 0.83% |
| 2020-12-31 | 0.81% |
| 2020-09-30 | 0.83% |
| 2020-06-30 | 1.40% |
| 2020-03-31 | 2.92% |
| 2019-12-31 | 2.29% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 92.44% |
